- Home
- OVID vs ANIX Comparison
OVID vs ANIX Comparison
Compare OVID & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- ANIX
- Stock Information
- Founded
- OVID 2014
- ANIX 1982
- Country
- OVID United States
- ANIX United States
- Employees
- OVID N/A
- ANIX N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- ANIX Health Care
- Exchange
- OVID Nasdaq
- ANIX Nasdaq
- Market Cap
- OVID 88.9M
- ANIX 95.7M
- IPO Year
- OVID 2017
- ANIX 1987
- Fundamental
- Price
- OVID $1.48
- ANIX $4.10
- Analyst Decision
- OVID Strong Buy
- ANIX Strong Buy
- Analyst Count
- OVID 4
- ANIX 3
- Target Price
- OVID $3.13
- ANIX $9.00
- AVG Volume (30 Days)
- OVID 5.7M
- ANIX 278.9K
- Earning Date
- OVID 11-11-2025
- ANIX 09-10-2025
- Dividend Yield
- OVID N/A
- ANIX N/A
- EPS Growth
- OVID N/A
- ANIX N/A
- EPS
- OVID N/A
- ANIX N/A
- Revenue
- OVID $6,651,000.00
- ANIX N/A
- Revenue This Year
- OVID $1,086.57
- ANIX N/A
- Revenue Next Year
- OVID N/A
- ANIX N/A
- P/E Ratio
- OVID N/A
- ANIX N/A
- Revenue Growth
- OVID 1070.95
- ANIX N/A
- 52 Week Low
- OVID $0.24
- ANIX $2.07
- 52 Week High
- OVID $2.01
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- OVID 50.82
- ANIX 56.53
- Support Level
- OVID $1.53
- ANIX $4.21
- Resistance Level
- OVID $1.79
- ANIX $4.67
- Average True Range (ATR)
- OVID 0.18
- ANIX 0.34
- MACD
- OVID -0.03
- ANIX 0.04
- Stochastic Oscillator
- OVID 34.42
- ANIX 50.67
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.